CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 628 enrolled
Drug / intervention
No interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01089582
NCT01089582N/ACompleted
CompareCT.gov

Quality Of Life Assessment In AD Patients Receiving Aricept Tablets (Donepezil Hydrochloride)

Pfizer·observational·Posted Mar 18, 2010·Updated Apr 28, 2011

In Brief

An observational study evaluating No intervention for Alzheimer Disease. Completed, enrolled 628 participants across 29 sites.

Detailed Summary

This study assessed the Hr QoL (Health related Quality of life) of subjects with mild to moderate AD, who received ARICEPT under usual clinical practice.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAlzheimer Disease
CountriesGreece
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 18, 2010
Enrollment StartNov 1, 2007
Primary CompletionJul 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 16.3 years ago

Interventions

No interventionother